Drug
Sot109
Sot109: highest development phase Phase 1/2, developed by SOTIO Biotech a.s.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- SOTIO Biotech a.s.
Trials
| Drug | Phase | Indication |
|---|---|---|
| SOT109 NCT07693751 | Phase 1/2 | Colorectal Cancer (Locally Advanced or Metastatic) |
Latest
No recent events.
Follow Sot109 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.